《美股業績》油服巨擘貝克休斯(BKR.US)季度收入勝預期
美國大型油服企業貝克休斯(Baker Hughes)(BKR.US)公佈去年第四季業績。季度純利2.94億美元,按年跌55%。每股季度攤薄純利32美仙,經調整後爲25美仙,差於市場預期的28美仙。季度收入55.19億美元,按年升0.4%,高於市場預期的54.9億美元。
公司季度自由現金流爲正數6.45億美元,經調整EBITDA按年升10%至8.44億美元。公司去年渦輪機械及處理方案部門錄得逾77億美元訂單,主要由液化天然氣相關需求推動。
公司股價昨日升1.6%報26.72美元,盤中曾升逾6%見27.88美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.